Regencell Bioscience Holdings Ltd RGC

$6.82 +0.49 (7.74%)

Valuation

Market cap
3,130,115,000
Revenue TTM
$0
Net income TTM
$-3,580,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
429,300
Avg volume
171,906
Day's range
$6.22 – $7.39
Shares out
494,489,000
Stochastic %K
63%
Beta
1.18
Analysts
Sell
Price target
$22.71

Price

Company profile

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong K...

Show more

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Phone
852 2155 0823
Website
https://www.regencellbioscience.com
Address
Chinachem Leighton Plaza, 9th Floor 29 Leighton Road, Causeway Bay, Hong Kong

Latest news